68817-134-50 |
68817-134 |
HUMAN PRESCRIPTION DRUG |
ABRAXANE |
Paclitaxel |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
INTRAVENOUS |
20050210 |
N/A |
NDA |
NDA021660 |
Abraxis BioScience, LLC |
PACLITAXEL |
100 mg/20mL |
1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) / 20 mL in 1 VIAL, SINGLE-USE |
24979-710-51 |
24979-710 |
HUMAN PRESCRIPTION DRUG |
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) |
Paclitaxel |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
INTRAVENOUS |
20220401 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021660 |
TWi Pharmaceuticals, Inc. |
PACLITAXEL |
100 mg/20mL |
1 VIAL, SINGLE-USE in 1 CARTON (24979-710-51) / 20 mL in 1 VIAL, SINGLE-USE |
60505-6230-4 |
60505-6230 |
HUMAN PRESCRIPTION DRUG |
Paclitaxel protein-bound particles for injectable suspension (albumin-bound) |
Paclitaxel |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
INTRAVENOUS |
20220401 |
N/A |
NDA AUTHORIZED GENERIC |
NDA021660 |
Apotex Corp. |
PACLITAXEL |
100 mg/20mL |
1 VIAL, SINGLE-USE in 1 CARTON (60505-6230-4) / 20 mL in 1 VIAL, SINGLE-USE |